| Gene-expression profiles in hereditary breast cancer I Hedenfalk, D Duggan, Y Chen, M Radmacher, M Bittner, R Simon, ... New England Journal of Medicine 344 (8), 539-548, 2001 | 2156 | 2001 |
| DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis M Esteller, MF Fraga, M Guo, J Garcia-Foncillas, I Hedenfalk, AK Godwin, ... Human molecular genetics 10 (26), 3001-3007, 2001 | 574 | 2001 |
| An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression A Palazon, PA Tyrakis, D Macias, P Veliça, H Rundqvist, S Fitzpatrick, ... Cancer cell 32 (5), 669-683. e5, 2017 | 376 | 2017 |
| Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program F Cardoso, JMS Bartlett, L Slaets, CHM Van Deurzen, ... Annals of Oncology 29 (2), 405-417, 2018 | 313 | 2018 |
| Molecular classification of familial non-BRCA1/BRCA2 breast cancer I Hedenfalk, M Ringnér, A Ben-Dor, Z Yakhini, Y Chen, G Chebil, R Ach, ... Proceedings of the National Academy of Sciences 100 (5), 2532-2537, 2003 | 246 | 2003 |
| Clinical and molecular complexity of breast cancer metastases S Kimbung, N Loman, I Hedenfalk Seminars in cancer biology 35, 85-95, 2015 | 164 | 2015 |
| RNA quality in frozen breast cancer samples and the influence on gene expression analysis–a comparison of three evaluation methods using microcapillary electrophoresis traces C Strand, J Enell, I Hedenfalk, M Fernö BMC molecular biology 8 (1), 1-9, 2007 | 137 | 2007 |
| MYB Oncogene Amplification in Hereditary BRCA1 Breast Cancer P Kauraniemi, I Hedenfalk, K Persson, DJ Duggan, M Tanner, ... Cancer research 60 (19), 5323-5328, 2000 | 131 | 2000 |
| Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker I Johansson, C Nilsson, P Berglund, M Lauss, M Ringnér, H Olsson, ... Breast Cancer Research 14, 1-15, 2012 | 126 | 2012 |
| Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk N Orr, A Lemnrau, R Cooke, O Fletcher, K Tomczyk, M Jones, N Johnson, ... Nature genetics 44 (11), 1182-1184, 2012 | 115 | 2012 |
| Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer K Rennstam, N McMichael, P Berglund, G Honeth, C Hegardt, L Rydén, ... Breast cancer research and treatment 122, 315-324, 2010 | 106 | 2010 |
| Gene expression in inherited breast cancer IA Hedenfalk, M Ringnér, JM Trent, A Borg Academic Press 84, 1-34, 2002 | 95 | 2002 |
| Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival NP Tobin, JC Harrell, J Lövrot, SE Brage, MF Stolt, L Carlsson, Z Einbeigi, ... Annals of oncology 26 (1), 81-88, 2015 | 94 | 2015 |
| High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer I Johansson, C Nilsson, P Berglund, C Strand, G Jönsson, J Staaf, ... Breast cancer research and treatment 129, 747-760, 2011 | 88 | 2011 |
| Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial M Feldt, O Bjarnadottir, S Kimbung, K Jirström, PO Bendahl, S Veerla, ... Journal of translational medicine 13 (1), 1-11, 2015 | 78 | 2015 |
| Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences S Kimbung, A Kovács, PO Bendahl, P Malmström, M Fernö, T Hatschek, ... Molecular oncology 8 (1), 119-128, 2014 | 73 | 2014 |
| Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer S Deb, I Johansson, D Byrne, C Nilsson, L Constable, ML Fjällskog, ... Modern Pathology 27 (9), 1223-1230, 2014 | 69 | 2014 |
| The landscape of candidate driver genes differs between male and female breast cancer I Johansson, M Ringnér, I Hedenfalk PloS one 8 (10), e78299, 2013 | 65 | 2013 |
| Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact C Nilsson, I Johansson, C Ahlin, S Thorstenson, RM Amini, M Holmqvist, ... Acta Oncologica, 2012 | 62 | 2012 |
| Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition S Kimbung, E Biskup, I Johansson, K Aaltonen, A Ottosson-Wadlund, ... Cancer letters 319 (2), 232-241, 2012 | 61 | 2012 |
Åke BorgDepartment of Oncology, Clinical Sciences, Lund University, SwedenVerified email at med.lu.se
